Skip to main content

Table 3 Changes in annual DDD and drug expenditures (year-to-year rates of increase in parenthesis)

From: Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea

  2005 2006 2007 2008 2009 2005-2009 Annual
Statin Sum of DDD 128,545,620 193,278,414 (50.36%) 274,288,699 (41.91%) 344,893,058 (25.74%) 445,426,185 246.51% 36.44%
Drug expenditure per DDD (unit: won) 1,506 1,392 1,276 1,185 1,085 −27.95% −7.87%
Total statin expenditure (unit: million won) 193.6 269.0 (38.96%) 350.0 (30.12%) 408.8 (16.82%) 483.1 (18.16%) 149.57% 25.69%
All Lipid-lowering drugs Sum of DDD 154,832,421 224,516,146 (45.01%) 314,095,889 (39.90%) 392,818,319 (25.06%) 506,311,055 (28.89%) 227.01% 34.47%
Drug expenditure per DDD (unit: won) 1,349 1,285 1,206 1,136 1,052 −22.02% −6.03%
  Total expenditure (unit: million won) 208.9 288.5 (38.09%) 378.7 (31.27%) 446.1 (17.82%) 532.5 (19.36%) 154.93% 26.36%
  1. * The drug expenditure was adjusted for inflation.